PortfoliosLab logo
BTAI vs. EPR
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between BTAI and EPR is 0.40, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

BTAI vs. EPR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in BioXcel Therapeutics, Inc. (BTAI) and EPR Properties (EPR). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Daily Std Dev

BTAI:

71.04%

EPR:

22.03%

Max Drawdown

BTAI:

-10.53%

EPR:

-82.02%

Current Drawdown

BTAI:

-10.53%

EPR:

-6.79%

Fundamentals

Market Cap

BTAI:

$8.37M

EPR:

$4.02B

EPS

BTAI:

-$23.51

EPR:

$1.63

PS Ratio

BTAI:

3.69

EPR:

5.77

PB Ratio

BTAI:

3.97

EPR:

1.73

Total Revenue (TTM)

BTAI:

$1.68M

EPR:

$517.64M

Gross Profit (TTM)

BTAI:

-$380.00K

EPR:

$431.94M

EBITDA (TTM)

BTAI:

-$21.06M

EPR:

$308.87M

Returns By Period


BTAI

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

EPR

YTD

22.31%

1M

12.70%

6M

21.11%

1Y

37.14%

5Y*

22.92%

10Y*

5.15%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BTAI vs. EPR — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BTAI
The Risk-Adjusted Performance Rank of BTAI is 77
Overall Rank
The Sharpe Ratio Rank of BTAI is 1515
Sharpe Ratio Rank
The Sortino Ratio Rank of BTAI is 11
Sortino Ratio Rank
The Omega Ratio Rank of BTAI is 33
Omega Ratio Rank
The Calmar Ratio Rank of BTAI is 11
Calmar Ratio Rank
The Martin Ratio Rank of BTAI is 1515
Martin Ratio Rank

EPR
The Risk-Adjusted Performance Rank of EPR is 8989
Overall Rank
The Sharpe Ratio Rank of EPR is 9393
Sharpe Ratio Rank
The Sortino Ratio Rank of EPR is 9090
Sortino Ratio Rank
The Omega Ratio Rank of EPR is 8888
Omega Ratio Rank
The Calmar Ratio Rank of EPR is 8383
Calmar Ratio Rank
The Martin Ratio Rank of EPR is 9191
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BTAI vs. EPR - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for BioXcel Therapeutics, Inc. (BTAI) and EPR Properties (EPR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.



Loading data...

Dividends

BTAI vs. EPR - Dividend Comparison

BTAI has not paid dividends to shareholders, while EPR's dividend yield for the trailing twelve months is around 6.50%.


TTM20242023202220212020201920182017201620152014
BTAI
BioXcel Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EPR
EPR Properties
6.50%7.68%6.81%8.62%3.16%4.66%6.37%6.75%6.23%5.35%6.21%5.91%

Drawdowns

BTAI vs. EPR - Drawdown Comparison

The maximum BTAI drawdown since its inception was -10.53%, smaller than the maximum EPR drawdown of -82.02%. Use the drawdown chart below to compare losses from any high point for BTAI and EPR. For additional features, visit the drawdowns tool.


Loading data...

Volatility

BTAI vs. EPR - Volatility Comparison


Loading data...

Financials

BTAI vs. EPR - Financials Comparison

This section allows you to compare key financial metrics between BioXcel Therapeutics, Inc. and EPR Properties. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00MAprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober
366.00K
164.04M
(BTAI) Total Revenue
(EPR) Total Revenue
Values in USD except per share items